Authors
1 Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran
2 Psychosomatic Medicine Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Education and Psychology, Khorasgan Branch, Islamic Azad University, Isfahan, Iran
4 Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Positive and negative emotional states are the most important factors in treatment and prevention process of psychosomatic diseases. This research aimed to investigate the effectiveness of emotional schemas' therapy on emotional schemas' modification and difficulties of emotion regulation in women with irritable bowel syndrome (IBS). Materials and Methods: This research was implemented in the framework of single-subject experimental design using step-wise multiple baselines plan. Five patients with IBS were selected as convenience sampling on the base of their willingness to participate and then they received emotional schema therapy (EST). Research tools included ROME III scale, SCID interview, emotional schemas questionnaire, and difficulties of emotional regulation. The analysis of data was done using visual analysis charts, recovery percentage, and reliable change index. Results: The results showed a decrease of scores in some maladaptive schemas and increase of some adaptive schemas than baseline in patients who received EST (P ≤ 0.05). Furthermore, this treatment decreased scores of some emotion regulation difficulty components (P ≤ 0.05). Conclusion: It seems that EST is an appropriate option for treatment of these patients because it is effective in improvement of emotional schemas and difficulties of emotional regulation.
Keywords
1. |
Phillips K, Wright BJ, Kent S. Psychosocial predictors of irritable bowel syndrome diagnosis and symptom severity. J Psychosom Res 2013;75:467-74. [PUBMED] |
2. | |
3. |
Wolitzky-Taylor K, Craske MG, Labus JS, Mayer EA, Naliboff BD. Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther 2012;50:647-50. [PUBMED] |
4. |
Burgell RE, Asthana AK, Gibson PR. Irritable bowel syndrome in quiescent inflammatory bowel disease: A review. Minerva Gastroenterol Dietol 2015;61:201-13. [PUBMED] |
5. |
Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006;130:1447-58. [PUBMED] |
6. | |
7. |
Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci 2014;264:651-60. [PUBMED] |
8. | |
9. | |
10. | |
11. | |
12. |
Peters SL, Muir JG, Gibson PR. Review article: Gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther 2015;41:1104-15. [PUBMED] |
13. | |
14. | |
15. |
Chilcot J, Moss-Morris R. Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention. Behav Res Ther 2013;51:690-5. [PUBMED] |
16. |
Tang QL, Lin GY, Zhang MQ. Cognitive-behavioral therapy for the management of irritable bowel syndrome. World J Gastroenterol 2013;19:8605-10. [PUBMED] |
17. |
Jang AL, Hwang SK, Kim DU. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: A randomized trial. Eur J Gastroenterol Hepatol 2014;26:918-26. [PUBMED] |
18. |
Li L, Xiong L, Zhang S, Yu Q, Chen M. Cognitive-behavioral therapy for irritable bowel syndrome: A meta-analysis. J Psychosom Res 2014;77:1-2. [PUBMED] |
19. |
Lackner JM, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J, et al. The irritable bowel syndrome outcome study (IBSOS): Rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemp Clin Trials 2012;33:1293-310. [PUBMED] |
20. | |
21. | |
22. |
Porcelli P, De Carne M, Leandro G. Alexithymia and gastrointestinal-specific anxiety in moderate to severe irritable bowel syndrome. Compr Psychiatry 2014;55:1647-53. [PUBMED] |
23. | |
24. | |
25. | |
26. | |
27. | |
28. | |
29. | |
30. |
Zorn P, Roder V, Soravia L, Tschacher W. Evaluation of the “Schema-focused emotive behavioural therapy” (SET) for patients with personality disorders: Results of a randomised controlled trial. Psychother Psychosom Med Psychol 2008;58:371-8. [PUBMED] |
31. | |
32. | |
33. | |
34. | |
35. |
Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-9. [PUBMED] |
36. | |
37. | |
38. | |
39. | |
40. | |
41. | |
42. | |
43. | |
44. |